Korea Biotech Increases Stake in Harim Holdings by 162,408 Shares, Holding Ratio Rises to 18.65%
Korea Biotech acquired 162,408 common shares of Harim Holdings via open market purchases, increasing its holdings to 20,892,408 shares (18.65% ownership, up from 18.51%).
The purchases were executed over 5 trading days (May 18–22, 2026) at an average price of KRW 12,196 per share, for a total of approximately KRW 1.98 billion.
The acquisition was carried out pursuant to a pre-announced trading plan filed on April 17, 2026, and represents a routine change in major shareholder ownership without any new capital raising purpose.
KOSDAQ Filing Information
Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders